Conditioned medium from normoxia (WJMSCs-norCM) and hypoxia-treated WJMSCs (WJMSCs-hypoCM) in inhibiting cancer cell proliferation
- 1 March 2015
- journal article
- Published by Elsevier BV in Biomarkers and Genomic Medicine
- Vol. 7 (1), 8-17
- https://doi.org/10.1016/j.bgm.2014.08.008
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Research and Technology (KP-2013-0715, KP-2014-0713)
- Stem Cell and Cancer Institute
This publication has 46 references indexed in Scilit:
- Antitumor Activities of Human Placenta-Derived Mesenchymal Stem Cells Expressing Endostatin on Ovarian CancerPLOS ONE, 2012
- The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activityGene Therapy, 2011
- Human umbilical cord matrix-derived stem cells expressing interferon-β gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID miceLung Cancer, 2010
- Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinomaBMC Cancer, 2010
- Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells DifferentiallyPLOS ONE, 2010
- Proteome analysis of human Wharton's jelly cells during in vitro expansionProteome Science, 2010
- Adipose Tissue–derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor GrowthMolecular Therapy, 2010
- Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivoCancer Letters, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Adult human mesenchymal stem cell as a target for neoplastic transformationOncogene, 2004